Inconvenient relationship of haemoglobin A1c level with endothelial function in type 2 diabetes in a cross-sectional study.

BMJ Open
Takayuki YamajiYukihito Higashi

Abstract

The aim of this study was to determine the relationship of haemoglobin A1c (HbA1c) level with flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID) in patients with type 2 diabetes. Cross-sectional study. 22 university hospitals and affiliated clinics in Japan. 1215 patients with type 2 diabetes including 349 patients not taking antidiabetic drugs. We evaluated FMD and HbA1c level. All patients were divided into four groups based on HbA1c level: <6.5%, 6.5%-6.9%, 7.0%-7.9% and ≥8.0%. An inverted U-shaped pattern of association between HbA1c level and FMD was observed at the peak of HbA1c of about 7%. FMD was significantly smaller in the HbA1c <6.5% group than in the HbA1c 6.5%-6.9% group and HbA1c 7.0%-7.9% group (p<0.001 and p<0.001), and FMD values were similar in the HbA1c <6.5% group and HbA1c ≥8.0% group. There were no significant differences in NID values among the four groups. After adjustments for confounding factors, FMD was significantly smaller in the HbA1c <6.5% group than in the HbA1c 6.5%-6.9% and HbA1c 7.0%-7.9% group (p=0.002 and p=0.04). In patients not taking antidiabetic drugs, FMD was also significantly smaller in the HbA1c <6.5% group than in the HbA1c 6.5%-6.9% group and HbA1c 7.0%...Continue Reading

References

Mar 1, 1996·Journal of the American College of Cardiology·S B WilliamsM A Creager
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
May 7, 2002·American Journal of Hypertension·Shota SasakiKazuaki Chayama
May 8, 2008·Diabetes/metabolism Research and Reviews·Rohana J Wright, Brian M Frier
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Feb 6, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Yukihito HigashiYasuki Kihara
Jul 1, 2010·The New England Journal of Medicine·UNKNOWN ACCORD Study GroupLawrence J Fine
Oct 12, 2010·The New England Journal of Medicine·Sophia ZoungasUNKNOWN ADVANCE Collaborative Group
Jul 9, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Junko SogaUNKNOWN ROCK Study Group
Nov 21, 2012·Journal of Korean Medical Science·Yoshiaki KubotaKyoichi Mizuno
Mar 23, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Tatsuya MaruhashiYukihito Higashi
Sep 4, 2013·European Heart Journal·Linda G MellbinHertzel C Gerstein
Jan 30, 2016·Journal of the American College of Cardiology·Eric Yuk Fai WanCindy Lo Kuen Lam
Mar 28, 2017·International Journal of Cardiology·Shogo MatsuiYukihito Higashi
Jul 21, 2017·Archives of Endocrinology and Metabolism·Lúcia Helena Bonalume TacitoJuan Carlos Yugar-Toledo
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Feb 7, 2018·International Journal of Cardiology·Yumiko IwamotoYukihito Higashi
Aug 16, 2018·The New England Journal of Medicine·Aidin RawshaniSoffia Gudbjörnsdottir

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

JMP Pro

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2021 Meta ULC. All rights reserved